Core Insights - PharmaCorp RX Inc. has completed the acquisition of three community pharmacy businesses, enhancing its presence in both Western and Eastern Canada [1][4] Western Canada Acquisitions - The company acquired two PharmaChoice Canada bannered pharmacies in Western Canada for an aggregate purchase price of $3,400,000, with 75% paid in cash and 25% through the issuance of common shares [2] - The common shares were priced based on the volume weighted average trading price on the TSX Venture Exchange over a specified period prior to the closing date [2] Eastern Canada Acquisition - PharmaCorp also acquired a PharmaChoice Canada bannered pharmacy in Eastern Canada for $5,300,000, funded through cash on hand and available credit [3] - No finder's fees were incurred in connection with these acquisitions [3] Strategic Growth - The acquisitions are part of PharmaCorp's disciplined growth strategy and strengthen its strategic alliance with PharmaChoice Canada [4] - The company aims to expand its national footprint while preserving independent legacies and ensuring continuity of care for patients [4] - PharmaCorp plans to remain active in pursuing further acquisitions in the near future [4] Company Overview - PharmaCorp currently operates seven PharmaChoice Canada bannered pharmacies and intends to continue acquiring both PharmaChoice and independently owned pharmacies [5] - The company is open to discussions with pharmacy owners considering succession or sale, emphasizing a commitment to seamless transitions [6]

Core Viewpoint - PharmaCorp RX Inc. has entered into definitive share purchase agreements to acquire a 100% interest in two PharmaChoice Canada pharmacies in Western Canada for an aggregate purchase price of $3,400,000 [1][2]. Acquisition Details - The purchase price will be satisfied with 75% cash and 25% through the issuance of common shares, with the share price based on the volume weighted average trading price over a specified period [2]. - The acquisitions are expected to close around October 1, 2025, pending customary closing conditions [3]. Strategic Implications - The transactions demonstrate PharmaCorp's capability to execute accretive acquisitions, aligning with its strategic alliance with PharmaChoice Canada [4]. - PharmaCorp currently operates four PharmaChoice Canada pharmacies and plans to continue acquiring more pharmacies under this brand [4].

Core Insights - PharmaCorp RX Inc. has secured a credit agreement with Canadian Imperial Bank of Commerce (CIBC) for up to $20,500,000 in committed credit facilities, which includes a $10,000,000 accordion feature and a $1,000,000 Visa credit facility to support its acquisition strategy and operational expansion [1][4][8] Credit Facilities - The credit facilities consist of a $17,500,000 committed acquisition term facility with a $10,000,000 accordion feature, allowing for increased borrowing capacity as acquisition opportunities arise, and a $3,000,000 committed revolving operating line for working capital [8] - A separate $5,000,000 credit facility is established to support the Pharmacist Co-Ownership Program, aimed at addressing the capital access challenges faced by pharmacists [2][3] Pharmacist Co-Ownership Program - The Pharmacist Co-Ownership Program provides loans to pharmacists wishing to acquire ownership in the PharmaCorp pharmacy where they work, financing up to 100% of their equity investment with competitive rates and repayment terms of up to 15 years [3][4] - This program is designed to remove barriers to ownership and facilitate long-term wealth creation for pharmacists through co-ownership with PharmaCorp [4] Company Operations - PharmaCorp currently operates four PharmaChoice Canada bannered pharmacies and plans to continue acquiring additional PharmaChoice Canada branded pharmacies as they become available [5] - The company is also open to acquiring independently owned non-PharmaChoice Canada bannered pharmacies and will operate them under the PharmaChoice Canada banner post-acquisition [5][6]

Core Points - PharmaCorp RX Inc. has agreed to acquire a 100% interest in a PharmaChoice Canada bannered pharmacy business for a purchase price of $2,400,000, expected to close around July 31, 2025 [1][2] - The acquisition will be funded using cash on hand and is subject to customary adjustments and a net asset value adjustment as of the closing date [1] - The company currently operates three PharmaChoice bannered pharmacies and plans to continue acquiring more as part of its strategic alliance with PharmaChoice Canada [2] Company Strategy - The acquisition reflects PharmaCorp's strategic alliance with PharmaChoice Canada and its disciplined acquisition strategy [2] - The company sees strong opportunities for growth and intends to remain active in pursuing further acquisitions in the coming months [2] - PharmaCorp will also consider acquiring independently owned non-PharmaChoice Canada bannered pharmacies and operate them under the PharmaChoice Canada banner [2]